Parkinson's Disease Trial, Recruiting NCT07207122 Sponsor: Sanmai Technologies PBC dba Sanmai Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07207122
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 22 and 80 years of age
  • People who have been diagnosed with idiopathic Parkinson's disease (the most common form of Parkinson's, not caused by another condition or medication)
  • People whose Parkinson's motor symptoms score at or above a certain level (25 or higher on a standard rating scale) when measured while not taking Parkinson's medication
  • People who have been on a stable Parkinson's medication routine for at least 30 days before joining the trial
  • People who are proficient in English
  • People with normal hearing and vision, or who use aids such as glasses or hearing devices to correct these
  • People who are able to give their own informed consent to participate, or who have a legally authorised representative available to do so on their behalf

Who may not be able to join:

  • People whose Parkinsonism is caused by another condition or is an atypical form of the disease
  • People who have previously had deep brain stimulation or any brain surgery
  • People whose score on a standard memory and thinking assessment (called the MoCA) falls below 23, which may indicate significant cognitive difficulties
  • People with serious psychiatric conditions, such as psychosis, active suicidal thoughts, or untreated major depression
  • People with a history of seizures or any known abnormality inside the skull or brain
  • People with a significant neurological disease, such as a brain tumour or multiple sclerosis
  • People for whom MRI or ultrasound scans are not safe or suitable (confirm with trial site)
  • People with unstable or poorly controlled general health conditions
  • People who currently have cancer, or who have had cancer within the past 5 years
  • People who are pregnant or breastfeeding
  • People who are currently participating in another interventional clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 408-455-3817

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sanmai Technologies PBC dba Sanmai
Registry
ClinicalTrials.gov
Start date
8 October 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in MDS-UPDRS Part III Total Score (OFF Medication State); Incidence of Serious Adverse Device Events (SADEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov